CN1047975A - A kind of compound method of anticancer agent - Google Patents
A kind of compound method of anticancer agent Download PDFInfo
- Publication number
- CN1047975A CN1047975A CN 89103767 CN89103767A CN1047975A CN 1047975 A CN1047975 A CN 1047975A CN 89103767 CN89103767 CN 89103767 CN 89103767 A CN89103767 A CN 89103767A CN 1047975 A CN1047975 A CN 1047975A
- Authority
- CN
- China
- Prior art keywords
- gram
- compound method
- mixing
- anticancer agent
- caoheche
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A kind of can be to the equal compound method of medicable anticancer agent of early, middle and late phase cancer.The anticancer agent made from this method also has prevention effects, and regularly the constant current modulation journey is taken, and the effect of anti-canceration, anti-innominate toxic swelling is arranged.
Description
The present invention relates to a kind of compound method of anticancer agent, especially the present invention relates to a kind of can be to the equal effective compound method of anticancer agent of early, middle and late phase cancer.
Existing to control the cancer method quite a lot, and its usefulness is respectively arranged, self-evident, but sum up and opinion, and its side effect is many slightly, and limitation is bigger during use, and all is to adopt with the rear in canceration, brings some miseries to patient.For example, the treating the poisonous disease with poisonous drugs method, mostly the cancer patient is a little less than the health that liver detoxification function is very little, then toxicity, poison amount are bigger often for medicine, thus increase the weight of disease sometimes on the contrary, even be directed at patient's premature death.Cobalt 60 radioactive methods and for example though inefficacy is not destroyed seriously to normal cell tissue, are directed at organ sometimes and damage, as esophagus embrittlement.Modus operandi is arranged again, and not only patient's misery, and survival rate is low, and it often can not adopt the cancer of late stage patient with severe symptoms.
Therefore, an object of the present invention is to provide a kind of compound method for preparing anticancer agent, the anticancer agent that utilizes this method to produce can remedy above-mentioned deficiency, is suitable for various cancers of treatment and various innominate toxic swelling, and the clothes back steadily has no side effect.
Another object of the present invention provide a kind of can be to the equal effective compound method of anticancer agent of early, middle and late phase cancer, all effective in cure with the anticancer agent that this method is made to early, middle and late phase cancer, and prevention effects is arranged, regularly the constant current modulation journey is taken, and the effect of anti-canceration, anti-toxic swelling is arranged.
Compound method reaches above-mentioned purpose of the present invention below using, this method is hybridly prepared into medicament with Spica Prunellae, Rhizoma Dioscoreae Bulbiferae, Cortex Dictamni, Radix Sophorae Tonkinensis, CAOHECHE, Herba Patriniae, Herba Hedyotidis Diffusae, Rhizoma Belamcandae under proper condition, wherein the consumption of each component is Spica Prunellae 1-18 gram, Rhizoma Dioscoreae Bulbiferae 1-35 gram, Cortex Dictamni 1-15 gram, Radix Sophorae Tonkinensis 1-35 gram, CAOHECHE 1-18 gram, Herba Patriniae 1-35 gram, Herba Hedyotidis Diffusae 1-16 gram, Rhizoma Belamcandae 1-15 gram.Be preferably Spica Prunellae 1-14 gram, Rhizoma Dioscoreae Bulbiferae 4-25 gram, Cortex Dictamni 4-12 gram, Radix Sophorae Tonkinensis 5-25 gram, CAOHECHE 6-13 gram, Herba Patriniae 3-20 gram, Herba Hedyotidis Diffusae 3-12 gram, Rhizoma Belamcandae 4-12 gram, said felicity condition is, do not influencing under the active ingredient prerequisite of above-mentioned each component, any condition is all applicable.Said mixing can directly mix each component with the form of raw material, also each component can be processed into powder, remix respectively earlier.Mixed medicament can directly be taken, and also can be processed into medical acceptable forms with existing processing technique of Chinese herbs.If directly take, preferably each component is taken after with powder mixes again.Mixed medicament can use existing pharmaceutical technology to be made into medical acceptable forms, for example capsule, close pill, tablet, concentrated pill, powder etc., also can use traditional immersion process to make oral liquid, also can use decocting for Chinese herbal medicine method commonly used, with its fried one-tenth decoction oral, also can make injection and other various medicine types through carrying choosing.
The compound method of anticancer agent according to the present invention, with the Spica Prunellae clearing away heat-fire, with the Rhizoma Dioscoreae Bulbiferae clearing away heat and cooling blood, with the Cortex Dictamni heat clearing and damp drying, and for restraining the primitive form of cancer, Radix Sophorae Tonkinensis, CAOHECHE, Herba Patriniae, Rhizoma Belamcandae, Herba Hedyotidis Diffusae with heat-clearing and toxic substances removing are the Main Ingredients and Appearance of gram cancer, and functions such as the heat-clearing and toxic substances removing that is had by itself, dispersing swelling and dissipating binds, blood stasis dispelling evacuation of pus, diuresis of blood circulation promoting reach purpose and the effect of controlling cancer.Control the cancer method relatively with other, have evident in efficacy, applied widely, no pain, the clothes back steadily, characteristics such as have no side effect.It has simultaneously, and the medical herbs figure place is few, and raw material is easy to get, and cost is low, and economic benefit is very remarkable, and preparation process is simple, the big remarkable advantage that waits of medical value.
With the medicine that prescription of the present invention is made into, all effective in cure to canceroderm, pulmonary carcinoma, hepatocarcinoma, gastric cancer, nasopharyngeal carcinoma, intestinal cancer, breast carcinoma and other various cancers and innominate toxic swelling.
Certain patient cattle * *, suffer from the canceroderm in late period, once take the medicine that many hospitals open, and accepted the treatment of some therapies, as the diathermy therapy, there is no effect.Take the medicament of the inventive method preparation, beginning obviously takes effect after half a year, and through taking more than a year, the cancer ulceration dwindles, and takes basic healing in 2 years, and this patient is the man at an advanced age, and is alive so far.
The patient who takes the medicament of the inventive method preparation mostly has reflection, the evacuation of pus of this medicine, functions of expelling toxin is better, take a period of time after, some patient is rushed down function by skin or physiology row on one's body and is discharged septicopyemia, and toxic swelling is eliminated.
Claims (9)
1, a kind of compound method of anticancer agent is characterized in that following composition Spica Prunellae, Rhizoma Dioscoreae Bulbiferae, and Cortex Dictamni, Radix Sophorae Tonkinensis, CAOHECHE, Herba Patriniae, Herba Hedyotidis Diffusae, Rhizoma Belamcandae mixes, the preparation anticancer agent.
2,, it is characterized in that the consumption of each component is respectively Spica Prunellae 1-18 gram, Rhizoma Dioscoreae Bulbiferae 1-35 gram according to the compound method of claim 1, Cortex Dictamni 1-15 gram, Radix Sophorae Tonkinensis 1-35 gram, CAOHECHE 1-18 gram, Herba Patriniae 1-35 gram, Herba Hedyotidis Diffusae 1-16 gram, Rhizoma Belamcandae 1-15 gram.
3,, it is characterized in that the consumption of various components is respectively Spica Prunellae 5-14 gram, Rhizoma Dioscoreae Bulbiferae 4-25 gram according to the compound method of claim 1, Cortex Dictamni 4-15 gram, Radix Sophorae Tonkinensis 2-25 gram, CAOHECHE 6-13 gram, Herba Patriniae 3-20 gram, Herba Hedyotidis Diffusae 3-12 gram, Rhizoma Belamcandae 4-12 gram.
4,, it is characterized in that each component is processed into the powder remix earlier is mixed with medical acceptable forms according to the compound method of claim 1.
5, according to the compound method of claim 4, it is characterized in that said mixing is the each component mix homogeneously that will exist with powder type with the mechanical agitation form, be mixed with medical acceptable medicament again.
6,, make pill in the close ball mode of making after it is characterized in that mixing according to the method for claim 5.
7,, be to make medicament after it is characterized in that mixing with the form of making capsule, tablet, concentrated pill, powder according to the method for claim 5.
8,, it is characterized in that mixing the back and make decoction with decoction method according to the compound method of claim 1.
9,, it is characterized in that mixing the back and make oral liquid with traditional immersion way according to the compound method of claim 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 89103767 CN1047975A (en) | 1989-06-13 | 1989-06-13 | A kind of compound method of anticancer agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 89103767 CN1047975A (en) | 1989-06-13 | 1989-06-13 | A kind of compound method of anticancer agent |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1047975A true CN1047975A (en) | 1990-12-26 |
Family
ID=4855266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 89103767 Pending CN1047975A (en) | 1989-06-13 | 1989-06-13 | A kind of compound method of anticancer agent |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1047975A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1052412C (en) * | 1994-08-09 | 2000-05-17 | 马洪万 | Cancer therapy injection |
CN1056773C (en) * | 1996-08-10 | 2000-09-27 | 王瑞林 | Recovery liquid for cancer and tumour |
CN1060941C (en) * | 1994-01-20 | 2001-01-24 | 胡学东 | Preparation and technology of active anticancer Chinese herbal medicine |
CN1082376C (en) * | 1998-12-03 | 2002-04-10 | 孙景华 | Pathogenic factor eliminating and healthy energy supporting anticancer medicine |
WO2002067961A3 (en) * | 2001-02-26 | 2003-05-15 | Global Cancer Strategies Ltd | Therapeutic uses of herbal compositions |
CN104542983A (en) * | 2014-12-15 | 2015-04-29 | 广东高鑫科技股份有限公司 | Formula milk powder for adjuvant therapy of cancer patients and preparation method thereof |
-
1989
- 1989-06-13 CN CN 89103767 patent/CN1047975A/en active Pending
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1060941C (en) * | 1994-01-20 | 2001-01-24 | 胡学东 | Preparation and technology of active anticancer Chinese herbal medicine |
CN1052412C (en) * | 1994-08-09 | 2000-05-17 | 马洪万 | Cancer therapy injection |
CN1056773C (en) * | 1996-08-10 | 2000-09-27 | 王瑞林 | Recovery liquid for cancer and tumour |
CN1082376C (en) * | 1998-12-03 | 2002-04-10 | 孙景华 | Pathogenic factor eliminating and healthy energy supporting anticancer medicine |
WO2002067961A3 (en) * | 2001-02-26 | 2003-05-15 | Global Cancer Strategies Ltd | Therapeutic uses of herbal compositions |
CN104542983A (en) * | 2014-12-15 | 2015-04-29 | 广东高鑫科技股份有限公司 | Formula milk powder for adjuvant therapy of cancer patients and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101797326B (en) | Chinese materia medica preparation for treating borborygmus diarrhoea and preparation method thereof | |
CN1196948A (en) | Full presciption medicine for treating rheumatism disease | |
CN1047975A (en) | A kind of compound method of anticancer agent | |
CN1093412C (en) | Chinese medicine for curing lithiasis | |
CN1134286A (en) | Zhuangguning-medicine for bone fracture | |
CN105998526A (en) | Chewable tablets for mainly treating anorexianervosa | |
CN104258359A (en) | Traditional Chinese medicine combination for curing pregnancy reaction and preparation method of preparations thereof | |
CN103933282B (en) | A kind of Chinese medicinal capsule for treating diabetes | |
CN1315186A (en) | Medical tea for treating leukoderma and its preparing process | |
JPH0761953B2 (en) | Manufacturing method of immunity strengthening and constitution improving agent | |
CN112755164A (en) | Traditional Chinese medicine composition for strengthening tendons and bones, preparation and application thereof | |
CN104435962A (en) | Pharmaceutical composition for treating dyspeptic diarrhea of piglets and preparation method thereof | |
CN1144595C (en) | Anticancer capsule | |
CN111671809A (en) | Medicament for treating cancer | |
CN100346821C (en) | Medicinal capsule for treating liver and gallbladder diseases and its preparing process | |
CN110141656A (en) | A kind of Fuke Tiaojing blood-nourishing Chinese medicine composition and preparation method thereof | |
CN1076608C (en) | Chinese medicine 'Jiaotai'an' | |
CN104800487B (en) | It is a kind of to be used to treat traditional Chinese medicinal ointment of chronic constipation and preparation method thereof | |
CN108310111B (en) | Traditional Chinese medicine formula for benefiting qi and nourishing blood, preparation method and application thereof, medicated diet for benefiting qi and nourishing blood and preparation method thereof | |
JP3355471B2 (en) | Pain health tea and its production method | |
JPH0798753B2 (en) | Composition for lowering blood glucose level | |
CN1050759C (en) | Medicinal composite for hysteromyoma and preparing method | |
CN113908208B (en) | Liver-protecting pharmaceutical composition and preparation method and application thereof | |
CN115845009B (en) | Navel moxibustion medicinal powder for treating spleen deficiency diarrhea and application thereof | |
CN1256958C (en) | Miao nationality medicine for treating enuresis and its compounding method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C01 | Deemed withdrawal of patent application (patent law 1993) | ||
WD01 | Invention patent application deemed withdrawn after publication |